Host genetic variation is a phenomenon of central importance for understanding basic principles of susceptibility to infection. Given the complex interactions at the molecular level between host cells and microorganisms, it is reasonable to expect that genetic variants of any of the host molecules involved in the host response to infection might alter the fate of the infectious agent within the host. Indeed, there is growing evidence that host genetic factors play a decisive role in several infectious diseases, including human immunodeficiency virus (HIV) infection, tuberculosis, malaria, schistosomiasis, and leprosy [1] . HIV infection commonly leads to AIDS, a major cause of morbidity and mortality around the world. Genetic variants of 2 genes, CCR5 and MBL, are associated with altered risk of HIV infection [2] [3] [4] . CCR5 functions as a receptor for HIV Received 25 March 1999 ; revised 23 June 1999; electronically published 17 September 1999.
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Financial support: Dirección Seccional de Salud de Antioquia, Medellín, Colombia; Fundació n para la Promoció n de la Investigación y la Tecnología, Santafé de Bogotá, Colombia; Canadian Genetic Diseases NetworkNetwork Centres of Excellence. E.S. is a chercheur boursier of the Fonds de la recherche en santé du Québec. invasion, a function that is abrogated in some HIV-resistant persons who carry a nonfunctional 32-bp deletion form of the CCR5 gene. The MBL alleles that are associated with reduced risk of HIV infection cause reduced levels of serum MBL [5] . However, the reason(s) for association of MBL levels with resistance to HIV infection is unknown.
Cells belonging to the monocyte/macrophage lineage play an important role during HIV infection. Consequently, genetic variants of any macrophage-expressed protein involved in macrophage-pathogen interaction could be risk modifiers for HIV infection. The human natural resistance-associated macrophage protein l (NRAMP1) gene has been linked to leprosy susceptibility [6] , and certain NRAMP1 alleles are associated with increased risk of pulmonary tuberculosis among West Africans [7] . Leprosy and tuberculosis are caused by Mycobacterium leprae and M. tuberculosis, respectively, two intracellular macrophage parasites. Moreover, in the murine Nramp1 protein, a single nonconservative aspartate-to-glycine amino acid substitution in predicted transmembrane domain 4 exerts a pleiotropic effect on macrophage functions, resulting in altered susceptibilities to a wide range of macrophage pathogens [8, 9] . These observations prompted us to investigate a possible association of HIV infection risk with NRAMP1 alleles.
Materials and Methods
Patients and controls. All subjects enrolled reside in the urban region of Medellín, Antioquia, Colombia. HIV-positive persons were enrolled either prospectively at the time of HIV infection diagnosis or retrospectively. HIV infection was determined serologically by detection of anti-HIV antibodies by standard clinical protocols. Healthy controls were enrolled from the general Medellin population. Genotyping.
For the intragenic NRAMP1 polymorphisms, choice of primers and polymerase chain reaction (PCR) was done as described elsewhere [10, 11] . NRAMP1 restriction fragment-length polymorphisms and repeat-length polymorphisms were typed by PCR as described elsewhere [11] . In addition, all DNAs were genotyped for the D2S104, D2S173, D2S424, D2S433, and D2S434 repeat-length polymorphisms to allow for testing of population substructure. D2S104 and D2S173 were typed by primers and amplification conditions as described by Spurr et al. [12] . Primers and amplification conditions for D2S424, D2S433, and D2S434 were obtained from public databases http://www. genome.wi.mit.edu and http://www.chlc.org. Exact allele sizes for all length polymorphisms were obtained by comparison of amplified alleles with multiple sequencing ladders and control DNAs of known allele size on each genotyping gel.
Statistical methods. To test for significant associations between HIV infection and NRAMP1 allele and genotype frequencies, x 2 tests for homogeneity of allele-phenotype tables were used. We used the StatXact-3 program (SPSS, Chicago) to generate the exact sampling distribution of x 2 and to obtain exact P values that are not limited by the restrictions of smaller samples and sparser tables. Relative risks (RRs) and 95% confidence intervals (CIs) were computed by use of the RERI program, which is part of the LINK-AGE-UTILITIES suite of programs (Rockefeller University, New York). For NRAMP1 haplotype association studies, frequencies of ambiguous haplotypes were estimated by use of the EH program, which is also part of the LINKAGE suite of programs [13] . Tests of genotypic linkage disequilibrium of the promoter region (GT)n repeat with the remaining markers and analysis of Hardy-Weinberg equilibrium of multiallelic markers were done with GenePop software [14] . For logistic regression modeling, we used the SPSS Professional Statistics package (version 7.5). Because not all subjects were typed for all markers, the results of the multiple logistic regression analysis are based on 281 persons (164 HIV positive, 117 HIV negative).
Results
To study the role of NRAMP1 in HIV infection, we enrolled 182 HIV-positive and 135 HIV-negative persons from the Medellin urban area. Because HIV infection in Medellin remains largely a male disease, there was an excess of men in the groups of HIV-positive (163 men, 19 women) and HIV-negative subjects (78 men, 57 women). For genetic analysis, we selected 6 NRAMP1 polymorphisms distributed along the entire NRAMP1 genomic sequence. The (GT)n and 3 untranslated region (UTR) polymorphisms are sequence-length variants located in the 5 and 3 UTRs of the gene, respectively [11] . The 4 remaining polymorphisms are single-nucleotide polymorphisms: 469ϩ14G/C is located in intron 4, and 274C/T and 823C/T represent silent bp substitutions located in the 5 (exon 3) and central region (exon 8) of NRAMP1, respectively [11] . Only the D543N polymorphism results in a nonconservative aspartate-to-asparagine change in the carboxy terminal end of the NRAMP1 protein.
The allele distribution for the selected NRAMP1 polymorphisms ordered from the 5 to the 3 region of the gene is shown in table 1. Alleles at the 274C/T, 469ϩ14G/C, and 823C/T polymorphisms showed significant evidence for association with HIV positivity. Alleles for all polymorphisms in both the HIVpositive patient and the HIV-negative control groups were in Hardy-Weinberg equilibrium. Moreover, both groups were in Hardy-Weinberg equilibrium for 4 of 5 microsatellites tested in the immediate vicinity of NRAMP1. These findings argue strongly against an inadvertently introduced population substructure in the groups of HIV-positive and HIV-negative subjects.
Next, we analyzed the genotype distribution for the 6 NRAMP1 polymorphisms among the HIV-positive and HIVnegative groups (table 2). We determined that in the HIV-negative controls, the (GT)n promoter repeat polymorphism was in strong genotypic linkage disequilibrium with the 274C/T and 469ϩ14G/C polymorphisms located in the 5 region of NRAMP1, but there was no evidence for genotypic linkage disequilibrium between the promoter and the 3 markers (823C/ T, D543N, 3 UTR) located in the central and 3 region of the gene (table 2) . The overall comparison of NRAMP1 genotypes for each polymorphism among the 2 groups indicated significant differences in the distribution of the (GT)n ( ). Because P = .020 P = .035 the (GT)n, 274C/T, and 469ϩ14G/C genotypes are not in linkage disequilibrium with the 823C/T polymorphism, this result shows the independent association of 2 NRAMP1 regions with HIV susceptibility. Homozygotes for the 288-bp allele in the Bivariate analysis suggested the likely effect of 4 individual NRAMP1 polymorphisms on HIV susceptibility. To further study the combined effect of these alleles on HIV positivity, we performed a multiple logistic regression analysis. The results of these analyses confirmed the findings obtained by bivariate analysis and did not provide evidence for a possible genotype interaction of the polymorphisms studied (data not shown). By forward selection based on score statistic, 274C/T was identified as a significant explanatory factor for HIV positivity (table 3) . Because 3 of the NRAMP1 markers associated with HIV positivity are in strong linkage disequilibrium (table 2) , different strategies for model building resulted in alternative models with similar explanatory powers. In addition, the 823C/T polymorphism had only weak explanatory power for HIV susceptibility (i.e., omission of this polymorphism had only borderline significant effects on the explanatory power of all tested models). Finally, because HIV infection in Medellin is a male-dominated disease, sex was a highly significant variable in all models tested (table 3) .
Discussion
We report the association of NRAMP1 alleles and genotypes with HIV positivity in a Colombian population. Although the phenotype analyzed was HIV infection, it will be of interest to test whether progression from infection to AIDS is also modulated by NRAMP1 alleles as we follow the HIV-positive persons in the coming years. Because population substructure can give rise to spurious associations in population-based case-control studies, we tested for such a possibly confounding effect by genotyping all subjects for 5 additional microsatellite markers in the immediate vicinity of NRAMP1. Careful analysis of the allele distribution in the groups of HIV-positive and -negative subjects did not provide evidence for population substructure. We also tested for the presence of the CCR5-D32-bp deletion allele as possible confounding factor. Although the deletion allele was more common among HIV-positive subjects (8 heterozygotes) than in HIV-negative controls (3 heterozygotes), the D32-bp CCR5 allele frequency in our population reached only 3.5%, and no person homozygous for the mutation was detected. No causal relationship between NRAMP1 alleles and risk of HIV infection susceptibility can be drawn from the observed association. Hence, our results do not allow us to conclude that NRAMP1 variants are the cause of increased or reduced risk of HIV infection. NRAMP1 is located in the gene-rich human chromosome 2q35 region, and it is possible that alleles of a second gene in tight linkage disequilibrium with NRAMP1 are the underlying cause of the observed nonrandom distribution of NRAMP1 genotypes among HIV-positive and -negative persons. For example, a tight linkage disequilibrium between the CCR2 and CCR5 alleles was described by Kostrikis et al. [15] , who suspected that the association of the CCR2-V64I allele with progression to disease could be due to a complete linkage disequilibrium of the CCR2 allele with a point mutation in the CCR5 regulatory region. Two known genes adjacent to NRAMP1 are the interleukin-8 receptor (IL-8R) a and b chain genes. Results obtained by Meddows-Taylor et al. [16] suggest that an altered IL-8R repertoire on neutrophils may be an important feature of HIV-1 pathogenesis, since the expression of IL-8R was significantly reduced in HIV-infected persons. However, considering the importance of monocytes and macrophages in the early phase of HIV infection [17] and that Nramp1 variants in mice and humans are important determinants of macrophage-mediated infectious disease susceptibility [18] [19] [20] , it seems likely that NRAMP1 itself is involved in the control of HIV susceptibility among exposed persons.
At present, the mechanistic basis of NRAMP1 function in susceptibility to HIV infection is unknown. Despite intensive comparative sequencing by us and by others, no polymorphism in the 5 region of the gene has been detected that would cause biologically significant amino acid changes in the NRAMP1 protein. Thus, it seems likely that the biologic effect of NRAMP1 alleles associated with HIV infection is mediated by altered expression levels of the NRAMP1 protein [21] . The 5 (GT)n-length variant could potentially influence NRAMP1 expression levels. By use of luciferase reporter gene constructs, Searle and Blackwell [22] showed that the 5 (GT)n-length variant directly affects the NRAMP1 promoter activity. Likewise, a biologic effect of the 469ϩ14G/C polymorphism could be mediated by possibly increasing the proportion of RNA molecules that carry an alternatively spliced exon 4 [23] . Because messengers carrying the alternatively spliced RNA give rise to a nonfunctional protein product, increased alternative splicing effectively reduces the quantity of expressed functional protein.
Moreover, we cannot exclude a direct biologic effect of the silent 274C/T and 823C/T polymorphisms associated with HIV susceptibility. Although rare, silent mutations (i.e., nucleotide changes that do not cause amino acid changes in the protein) can cause disease by altering exon regulatory elements that affect RNA splicing [24, 25] . These possibilities are being addressed by additional experiments.
